vs
Side-by-side financial comparison of LESAKA TECHNOLOGIES INC (LSAK) and Xylem Inc. (XYL). Click either name above to swap in a different company.
LESAKA TECHNOLOGIES INC is the larger business by last-quarter revenue ($3.0B vs $2.1B, roughly 1.4× Xylem Inc.). Xylem Inc. runs the higher net margin — 8.9% vs 0.0%, a 8.9% gap on every dollar of revenue. On growth, Xylem Inc. posted the faster year-over-year revenue change (2.7% vs 0.2%). Over the past eight quarters, LESAKA TECHNOLOGIES INC's revenue compounded faster (352.8% CAGR vs -1.0%).
Lesaka Technologies is a South-African financial technology company that is listed on the NASDAQ and Johannesburg Stock Exchange. Lesaka’s primary focus is on financial inclusion, offering financial services to previously underserved communities and merchants.
Xylem is one of the two types of transport tissue in vascular plants, the other being phloem; both of these are part of the vascular bundle. The basic function of the xylem is to transport water upward from the roots to parts of the plants such as stems and leaves, but it also transports nutrients. The word xylem is derived from the Ancient Greek word ξύλον (xúlon), meaning "wood"; the best-known xylem tissue is wood, though it is found throughout a plant.
LSAK vs XYL — Head-to-Head
Income Statement — Q1 FY2027 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.0B | $2.1B |
| Net Profit | $437.0K | $189.0M |
| Gross Margin | — | 37.8% |
| Operating Margin | 2.2% | 11.5% |
| Net Margin | 0.0% | 8.9% |
| Revenue YoY | 0.2% | 2.7% |
| Net Profit YoY | — | 100.0% |
| EPS (diluted) | — | $0.79 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 26 | $3.0B | — | ||
| Q1 26 | — | $2.1B | ||
| Q4 25 | $178.7M | $2.4B | ||
| Q3 25 | $171.4M | $2.3B | ||
| Q2 25 | $168.5M | $2.3B | ||
| Q1 25 | $161.4M | $2.1B | ||
| Q4 24 | $176.2M | $2.3B | ||
| Q3 24 | $153.6M | $2.1B |
| Q3 26 | $437.0K | — | ||
| Q1 26 | — | $189.0M | ||
| Q4 25 | $3.6M | $335.0M | ||
| Q3 25 | $-4.3M | $227.0M | ||
| Q2 25 | $-28.4M | $226.0M | ||
| Q1 25 | $-22.1M | $169.0M | ||
| Q4 24 | $-32.5M | $326.0M | ||
| Q3 24 | $-4.5M | $217.0M |
| Q3 26 | — | — | ||
| Q1 26 | — | 37.8% | ||
| Q4 25 | 31.4% | 38.9% | ||
| Q3 25 | 30.9% | 38.9% | ||
| Q2 25 | 28.9% | 38.8% | ||
| Q1 25 | 27.5% | 37.1% | ||
| Q4 24 | 25.7% | 38.0% | ||
| Q3 24 | 22.6% | 37.3% |
| Q3 26 | 2.2% | — | ||
| Q1 26 | — | 11.5% | ||
| Q4 25 | 1.2% | 14.7% | ||
| Q3 25 | 0.2% | 14.7% | ||
| Q2 25 | -16.7% | 13.3% | ||
| Q1 25 | 0.4% | 11.2% | ||
| Q4 24 | 0.3% | 11.8% | ||
| Q3 24 | -0.0% | 13.3% |
| Q3 26 | 0.0% | — | ||
| Q1 26 | — | 8.9% | ||
| Q4 25 | 2.0% | 14.0% | ||
| Q3 25 | -2.5% | 10.0% | ||
| Q2 25 | -16.9% | 9.8% | ||
| Q1 25 | -13.7% | 8.2% | ||
| Q4 24 | -18.4% | 14.5% | ||
| Q3 24 | -3.0% | 10.3% |
| Q3 26 | — | — | ||
| Q1 26 | — | $0.79 | ||
| Q4 25 | $0.04 | $1.37 | ||
| Q3 25 | $-0.05 | $0.93 | ||
| Q2 25 | $-0.40 | $0.93 | ||
| Q1 25 | $-0.27 | $0.69 | ||
| Q4 24 | $-0.40 | $1.33 | ||
| Q3 24 | $-0.07 | $0.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5B | $808.0M |
| Total DebtLower is stronger | $3.2B | $1.9B |
| Stockholders' EquityBook value | — | $11.0B |
| Total Assets | $11.5B | $17.0B |
| Debt / EquityLower = less leverage | — | 0.18× |
8-quarter trend — quarters aligned by calendar period.
| Q3 26 | $1.5B | — | ||
| Q1 26 | — | $808.0M | ||
| Q4 25 | $69.5M | $1.5B | ||
| Q3 25 | $72.2M | $1.2B | ||
| Q2 25 | $76.5M | $1.2B | ||
| Q1 25 | $71.0M | $1.1B | ||
| Q4 24 | $60.6M | $1.1B | ||
| Q3 24 | $49.7M | $989.0M |
| Q3 26 | $3.2B | — | ||
| Q1 26 | — | $1.9B | ||
| Q4 25 | $216.8M | $2.0B | ||
| Q3 25 | $208.1M | $2.0B | ||
| Q2 25 | $200.8M | $2.0B | ||
| Q1 25 | $194.7M | $2.0B | ||
| Q4 24 | $148.7M | $2.0B | ||
| Q3 24 | $148.5M | — |
| Q3 26 | — | — | ||
| Q1 26 | — | $11.0B | ||
| Q4 25 | $180.6M | $11.5B | ||
| Q3 25 | $170.4M | $11.2B | ||
| Q2 25 | $161.6M | $11.1B | ||
| Q1 25 | $185.2M | $10.8B | ||
| Q4 24 | $193.3M | $10.6B | ||
| Q3 24 | $184.2M | $10.6B |
| Q3 26 | $11.5B | — | ||
| Q1 26 | — | $17.0B | ||
| Q4 25 | $704.6M | $17.6B | ||
| Q3 25 | $652.9M | $17.3B | ||
| Q2 25 | $653.7M | $17.2B | ||
| Q1 25 | $649.2M | $16.6B | ||
| Q4 24 | $640.6M | $16.5B | ||
| Q3 24 | $551.9M | $16.0B |
| Q3 26 | — | — | ||
| Q1 26 | — | 0.18× | ||
| Q4 25 | 1.20× | 0.17× | ||
| Q3 25 | 1.22× | 0.18× | ||
| Q2 25 | 1.24× | 0.18× | ||
| Q1 25 | 1.05× | 0.19× | ||
| Q4 24 | 0.77× | 0.19× | ||
| Q3 24 | 0.81× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LSAK
Segment breakdown not available.
XYL
| Revenue from products | $1.8B | 83% |
| Revenue from services | $368.0M | 17% |
